hospitalised
[용어속성] abnormalities
Long Covid in adults discharged from UK hospitals after Covid-19: A prospective, multicentre cohort study using the ISARIC WHO Clinical Characterisation Protocol ^ ^^
Research Paper
[키워드] 95% CI
acute illness
adjusted
Adults
age
breathless
breathlessness
clinical
cohort study
COVID-19
Department
development
discharged
Dyspnoea
Effect
fatigue
females
finding
FIVE
foundation
funding
greater
healthy
hospitalisation
hospitalised
increase in
initial
ISARIC
less
Long
long-COVID
Long-term outcomes
median
Melinda Gate
men
MRC
multicentre
New
outcome
participant
Participants
post-acute COVID-19
Post-COVID
Primary outcome
Quality of life
recruited
reduced
reported
SARS-COV-2 infection
secondary
Sequelae
Seven
significantly
symptom onset
Symptoms
UK hospital
Washington
WHO
[DOI] 10.1016/j.lanepe.2021.100186 PMC 바로가기 [Article Type] Research Paper
[DOI] 10.1016/j.lanepe.2021.100186 PMC 바로가기 [Article Type] Research Paper
Remdesivir for the treatment of COVID-19
코로나19 치료제 렘데시비르
Article
[키워드] 95% CI
95% confidence interval
adverse event
adverse events
age
all-cause mortality
antiviral medicine
approach
authorisation
baseline
CENTRAL
certainty
certainty of evidence
chance
citation
clinical
Clinical improvement
Clinical outcome
clinical outcomes
clinical status
Cochrane COVID-19 Study Register
comparable
conducted
contribute
Controlled
controlled trials
coronavirus disease
coronavirus diseases
COVID-19
COVID-19 patient
COVID-19 patients
COVID-19 research
Data collection
decrease
defined
diagnosed
died
disease severity
Effect
Efficacy and safety
Emergency use
Ethnicity
evaluated
Evidence
excluded
FIVE
Future
Gender
high risk
High-flow oxygen
hospitalised
hospitalised patient
Hospitalised patients
identify
increase
index
individual
information
inhibit
initial
Invasive mechanical ventilation
lack
liberation
life
low-flow oxygen
maintain
Mask
mechanical ventilation
media
medRxiv
methodology
Missing data
missing value
missing values
Mortality
MOST
nasal prong
nasal prongs
need for oxygen
no difference
no effect
Non-invasive
non-invasive mechanical ventilation
non-invasive ventilation
observation
outcome
outcomes
oxygen
participant
Participants
Patient
Placebo
potential benefit
potential benefits
Quality of life
randomised
randomised controlled trial
Randomised controlled trials
RCT
RCTs
receive
recruit
registry
Remdesivir
reported
required
Respiratory Support
risk
risk difference
risk of bia
risk ratio
RoB 2
SARS-CoV-2
SARS-COV-2 infection
Science Citation Index
searched
Selection
Serious Adverse Event
Serious Adverse Events
severity
Source
standard care
subgroup
subgroups
supplemental oxygen
systematic review
Treatment
viral replication
Web of Science
WHO
WHO International Clinical Trials Registry Platform
worsening
[DOI] 10.1002/14651858.CD014962 PMC 바로가기 [Article Type] Article
[DOI] 10.1002/14651858.CD014962 PMC 바로가기 [Article Type] Article
Reduction in hospitalised COPD exacerbations during COVID-19: A systematic review and meta-analysis
Research Article
[키워드] 95% CI
95% confidence interval
Abstract
Admission
chronic obstructive
conducted
Containment
COPD
coronavirus disease
COVID-19
COVID-19 pandemic
database
determine
eligible
Exacerbation
finding
Future
Hospital admission
Hospital admissions
hospitalised
incidence
inclusion criteria
Inconclusive
independent
index
infection control
magnitude
measure
Meta-analysis
nine
pandemic
pooled rate
pulmonary disease
random effect model
recommendation
reduce
reduction
reduction in
report
reported
respiratory viral infection
respiratory virus
Result
screened
searched
significant decrease
suggested
synthesised
systematic review
the Newcastle-Ottawa Scale
was used
[DOI] 10.1371/journal.pone.0255659 PMC 바로가기 [Article Type] Research Article
[DOI] 10.1371/journal.pone.0255659 PMC 바로가기 [Article Type] Research Article
Prevalence and significance of pulmonary disease on lung ultrasonography in outpatients with SARS-CoV-2 infection
SARS-CoV-2 감염 외래 환자의 폐 초음파 검사에서 폐질환의 유병률과 중요성
Article
[키워드] adverse outcomes
Analysis
broad spectrum
Clinical outcome
clinical outcomes
Clinical significance
Cohort
Comorbidities
Comorbidity
consolidations
correlated
correlations
COVID-19
COVID-19 pneumonia
demographics
diagnosed
died
evaluated
hospitalised
identify
identifying
imaging/CT MRI etc
Infection
interstitial pneumonia
lack
lung
majority
mechanical ventilation
MRI
Multivariate analysis
natural history
Outpatient
outpatients
Patient
Patient symptoms
patients with SARS-CoV-2
Pneumonia
positive
Prevalence
pulmonary disease
pulmonary involvement
required
risk stratification
SARS-CoV-2
SARS-COV-2 infection
SARS-CoV-2 PCR
Severity Score
Shortness of breath
subset
were assessed
[DOI] 10.1136/bmjresp-2021-000947 PMC 바로가기 [Article Type] Article
[DOI] 10.1136/bmjresp-2021-000947 PMC 바로가기 [Article Type] Article
Association between pre-existing respiratory disease and its treatment, and severe COVID-19: a population cohort study
Articles
[키워드] Admission
Admissions
admitted to ICU
Affect
allergic
Asthma
chronic obstructive
chronic respiratory disease
Cohort
cohort study
Comorbidity
contribute
COPD
COVID-19
Cox regression
database
death
died
Diseases
England
English
examined
extrinsic
finding
funding
General population
hazard ratio
higher risk
hospital
Hospital admissions
hospitalisation
hospitalised
ICS
ICU
ICU admission
increased risk
individual
Inhaled
inhaled corticosteroid
intensive care
Interstitial lung disease
introduced
lung cancer
Lung disease
Older
Oxford
Patient
people with asthma
post-hoc analysis
Prevalence
previous study
Public Health England
pulmonary disease
pulmonary fibrosis
QResearch
Registered
Respiratory disease
risk
risk of death
sarcoidosis
SARS-CoV-2 testing
severe COVID-19
severe disease
shielding
steroid
suggested
the epidemic
Treatment
Wellcome Trust
with COVID-19
[DOI] 10.1016/S2213-2600(21)00095-3 PMC 바로가기 [Article Type] Articles
[DOI] 10.1016/S2213-2600(21)00095-3 PMC 바로가기 [Article Type] Articles
Symptoms in patients with asthma infected by SARS-CoV-2
Observational Study
[키워드] age
aggravate
Asthma
Asymptomatic
COVID-19
develop
females
FIVE
Hospital admission
hospitalised
infected with SARS-CoV-2
Mild
moderate
one patient
Patient
phenotype
Pneumonia
positive
respiratory tract
RT-PCR
SARS-CoV-2
SARS-COV-2 infection
severity
statistically significant
susceptibility
Symptom
Symptoms
tested
the disease
the patient
therapy
tropism of SARS-CoV-2
virus
were recorded
wheeze
wheezing
[DOI] 10.1016/j.rmed.2021.106495 PMC 바로가기 [Article Type] Observational Study
[DOI] 10.1016/j.rmed.2021.106495 PMC 바로가기 [Article Type] Observational Study
Co-infections, secondary infections, and antimicrobial use in patients hospitalised with COVID-19 during the first pandemic wave from the ISARIC WHO CCP-UK study: a multicentre, prospective cohort study
Articles
[키워드] Admission
Against
age
analysed
antimicrobial
available data
Bacterial infection
bloodstream
carbapenem
case report form
caused
CCP-UK
characterisation
clinical
clinically
Co-infection
collected
Community
concerning
conducted
Critical care
Culture
demographic
Department
development
diagnosed
eligible
England
Enterobacteriaceae
Escherichia coli
European
excluded
female
finding
for inclusion
foundation
Frequency
funding
Haemophilus influenzae
highest
hospital
Hospital admission
hospitalised
Imperial College London
Infection
Inpatient
Intervention
IQR
ISARIC
ISARIC WHO CCP-UK
Laboratory
likelihood
median
Medical Research Council
Melinda Gate
microbiologically
multicentre
NIHR
NIHR HPRU
organism
outcome
pandemic
pathogen
Pathogens
Patient
patients
patients with COVID-19
predominant
prospective cohort study
protection
recorded
respiratory
SARS-COV-2 infection
SARS-CoV-2 test
Secondary infection
secondary infections
secondary respiratory infections
Staphylococcus aureus
target
therapeutic
unit
University of Liverpool
Wellcome Trust
were excluded
were recorded
WHO
with COVID-19
[DOI] 10.1016/S2666-5247(21)00090-2 PMC 바로가기 [Article Type] Articles
[DOI] 10.1016/S2666-5247(21)00090-2 PMC 바로가기 [Article Type] Articles
Efficacy of convalescent plasma for treatment of COVID-19 in Uganda
Randomized Controlled Trial
[키워드] African
Arm
benefit
CCP
CCP therapy
clinical
clinical status
convalescent plasma
COVID-19
deaths
defined
determine
Disease progression
disease severity
Efficacy
hospitalised
Improvements
male
median
median age
Mortality
not different
outcome
oxygen
oxygen saturation
Patient
patients
plasma
positive
potential therapy
Primary outcome
progression
randomised
receive
respiratory infection
SARS-CoV-2
scale
secondary
secondary outcome
Standard of care
statistically significant difference
subgroups of patient
Symptom
symptom resolution
the median
time
transcriptase
Treatment
Trial
Uganda
viral clearance
viral infection
Virological
WHO
[DOI] 10.1136/bmjresp-2021-001017 PMC 바로가기 [Article Type] Randomized Controlled Trial
[DOI] 10.1136/bmjresp-2021-001017 PMC 바로가기 [Article Type] Randomized Controlled Trial
Variation in COVID-19 characteristics, treatment and outcomes in Michigan: an observational study in 32 hospitals
Observational Study
[키워드] Admission
age
Antibiotic therapy
body mass index
Cardiopulmonary
Care
Characteristics
Clinical data
collected
Corticosteroid
COVID-19
discharge
discharged
Fever
guidelines
healthcare
hospital
hospitalisation
hospitalised
hospitals
Hydroxychloroquine
ICU
ICU patient
in-hospital mortality
information
intensive care
mechanical ventilation
median
Mortality
nasal
outbreak
outcome
Patient
patients
patients died
proportion
protocol
protocols &
quality in healthcare
ranged
reported
retrospective cohort study
Shortness of breath
subset
Symptoms
the median
therapy
treated
Treatment
Venous Thromboembolism
with COVID-19
[DOI] 10.1136/bmjopen-2020-044921 PMC 바로가기 [Article Type] Observational Study
[DOI] 10.1136/bmjopen-2020-044921 PMC 바로가기 [Article Type] Observational Study